John T. Carpenter

6.2k citations
64 papers · 2.7k · 1 hit paper · h-index 21

Impact in

    • Breast Cancer Treatment Studies
  • Oncology top 2%
    • Cancer Treatment and Pharmacology
    • Colorectal Cancer Treatments and Studies
    • HER2/EGFR in Cancer Research
    • Pancreatic and Hepatic Oncology Research
    • Neutropenia and Cancer Infections

Papers in

    • Cancer Treatment and Pharmacology 12
    • Colorectal Cancer Treatments and Studies 5
    • Neutropenia and Cancer Infections 4
    • HER2/EGFR in Cancer Research 3
    • Breast Cancer Treatment Studies 14

John T. Carpenter

53 papers receiving 2.5k citations

John T. Carpenter's Hit Papers

Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer 2003 · 925 citations
9250+7+15Years since publication250500750

Peers

John T. Carpenter
Comparison fields: 5 of 139
  • Cancer Research 872
  • Oncology 1.4k
  • Pathology and Forensic Medicine 243
  • Microbiology 8
  • Emergency Medicine 74
Replace Lukas Hefler with:
Lukas Hefler Austria
Pax H.B. Willemse Netherlands
Rolf Kåresen Norway
Peter J. Rosen United States
John H. Kearsley Australia
Ping Jiang China
H.T. Ford United Kingdom
E. Terzoli Italy
R.D. Rubens United Kingdom
Wolfgang Hiddemann Germany
John T. Carpenter relative to Lukas Hefler Austria Lukas Hefler's profile →
Citations per field
00.5×1.5×2.2×
Lukas Hefler · 1×
Citations per year

Countries citing papers authored by John T. Carpenter

Since Specialization
Citations

This map shows the geographic impact of John T. Carpenter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John T. Carpenter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John T. Carpenter more than expected).

Fields of papers citing papers by John T. Carpenter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John T. Carpenter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John T. Carpenter. The network helps show where John T. Carpenter may publish in the future.

Co-authors

The 25 scholars most cited alongside John T. Carpenter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John T. Carpenter Line = papers co-authored together John T. Carpenter links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer
Hit paper breakdown →
2003925
2 1988400
3 1991183
4 1986118
5 197798
6
Decreased dihydropyrimidine dehydrogenase activity in a population of patients with breast cancer: implication for 5-fluorouracil-based chemotherapy.
199888
7 199179
8 198378
9 198378
10 199276
11 200968
12 200364
13 197542
14 198233
15 201131
16 201029
17 198824
18
Epithelioid hemangioendothelioma: CT manifestations and possible linkage to vinyl chloride exposure.
199124
19 199121
20 198420

About John T. Carpenter

John T. Carpenter is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 64 papers that have together received 2.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (14 papers), Cancer Treatment and Pharmacology (12 papers), Colorectal Cancer Treatments and Studies (5 papers), Estrogen and related hormone effects (4 papers), Neutropenia and Cancer Infections (4 papers), Breast Lesions and Carcinomas (4 papers), HER2/EGFR in Cancer Research (3 papers) and Advanced Breast Cancer Therapies (3 papers). The work is most often cited by research in Cancer Research (872 citations), Oncology (1.4k citations), Pathology and Forensic Medicine (243 citations), Microbiology (8 citations) and Emergency Medicine (74 citations). John T. Carpenter has collaborated with scholars based in United States, Puerto Rico and Pakistan. Frequent co-authors include Robert B. Diasio, Barry Harris, David B. Duggan, I. Craig Henderson, William C. Wood, Katherine H. R. Tkaczuk, Emil Frei, M. Robert Cooper, Lori J. Goldstein and James F. Holland. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Cancer Research, Breast Cancer Research and Treatment and Journal of Computer Assisted Tomography.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact